FTC Scrutinizes Hims & Hers Data…FTC Scrutinizes Hims & Hers Data Practices

The Federal Trade Commission is pursuing Hims & Hers and other telehealth companies over alleged disclosure of sensitive health information, difficult-to-cancel subscriptions, and limited real-time physician consultations. The cases highlight regulatory gaps because HIPAA does not cover many direct-to-consumer services, leaving FTC enforcement and state privacy laws as primary safeguards. Research on GLP-1 providers also indicates that live clinician consultations are not consistently required. Hims & Hers disputes the allegations, while the legal pressure may affect its marketing model, growth expectations, and investor outlook.